Home page | Biomarker Research
We would like to show you a description here but the site won’t allow us.
Proteomics in pancreatic cancer - Biomarker Research
Jul 6, 2025 · While CA19-9 remains the cornerstone biomarker for these purposes, several emerging protein biomarkers are enhancing clinical applications. For example, cytokeratin 19-fragments …
Copper homeostasis and copper-induced cell death in tumor immunity ...
Oct 31, 2024 · Cai Y, He Q, Liu W, Liang Q, Peng B, Li J, et al. Comprehensive analysis of the potential cuproptosis-related biomarker LIAS that regulates prognosis and immunotherapy of pan-cancers.
Metabolic regulation of tumor-associated macrophage heterogeneity ...
Jan 7, 2024 · Review Open access Published: 07 January 2024 Metabolic regulation of tumor-associated macrophage heterogeneity: insights into the tumor microenvironment and …
Novel immunotargets in multiple myeloma: biological relevance and ...
Jul 1, 2025 · This soluble form may act as a decoy, potentially reducing the efficacy of DPP4-targeted therapies. On the other hand, circulating soluble DPP4 has been studied as a biomarker in various …
It is also frequently claimed to be a biomarker of diseases such as cancer and heart disease in bodily-fluid based miRNA studies. Here we dissociate its contributions to cellular physiology and pathology …